Secretory Carcinoma of the Breast: Clinical Characteristics and Surgical Management

Secretory Carcinoma of the Breast: Clinical Characteristics and Surgical Management

1. Introduction to Secretory Carcinoma Secretory carcinoma of the breast is an exceptionally rare, morphologically distinct subtype of invasive breast malignancy. Originally termed “juvenile breast carcinoma” due to its initial discovery in pediatric patients, it is now recognized that this specific neoplasm can develop in individuals across a vast age spectrum. The defining clinical feature … Read more

Atypical Medullary Carcinoma: Clinical Guide and Treatment

Atypical Medullary Carcinoma: Clinical Guide and Treatment

1. Introduction Atypical medullary carcinoma is a specialized histological classification of invasive breast neoplasia. This diagnosis is applied to tumors that exhibit many of the cellular hallmarks of classic medullary carcinoma but fail to meet all the strict pathological criteria required for that specific designation. The presence of these atypical features places the tumor in … Read more

Nottingham Combined Grade II: 6-7 Points Explained

Nottingham Combined Grade II: 6-7 Points Explained

1. Introduction Nottingham Combined Grade II indicates an intermediate tumor grade in breast cancer pathology. This grade is assigned when a tissue sample receives a combined score of six or seven points on the Nottingham grading system. The score reflects how closely the breast cancer cells resemble normal breast tissue and provides insight into how … Read more

Nottingham Combined Grade III: 8-9 Points Explained

Nottingham Combined Grade III: 8-9 Points Explained

1. Introduction Nottingham Combined Grade III signifies a high-grade tumor in breast cancer pathology. This grade is determined when a tissue sample yields a combined score of eight or nine points under microscopic evaluation. A Grade III result indicates that the cancer cells look significantly different from normal breast cells and are dividing at a … Read more

Veppanu (Vepdegestrant): Uses, Side Effects & Interactions

Veppanu (Vepdegestrant): Uses, Side Effects & Interactions

1. Introduction & Mechanism of Action of Veppanu Veppanu is a targeted oral antineoplastic agent containing vepdegestrant, utilized for the treatment of estrogen receptor positive, human epidermal growth factor receptor two negative advanced or metastatic breast cancer. Its most prominent clinical side effect is a significant alteration in hematological parameters, particularly a decrease in white … Read more

Infiltrating Ductal Carcinoma of the Breast: Diagnosis and Treatment Options

Infiltrating Ductal Carcinoma of the Breast: Diagnosis and Treatment Options

1. Introduction to Infiltrating Ductal Carcinoma Infiltrating ductal carcinoma, also recognized in clinical literature as invasive ductal carcinoma, is the most frequently diagnosed histological type of breast cancer. The immediate clinical reality is that malignant epithelial cells have originated within the milk ducts of the breast and subsequently broken through the ductal basement membrane. This … Read more

Hormone Receptor Positive Malignant Neoplasm of Breast: Pathology, Diagnosis, and Endocrine Therapy

Hormone Receptor Positive Malignant Neoplasm of Breast: Pathology, Diagnosis, and Endocrine Therapy

1. Introduction to Hormone Receptor Positive Breast Neoplasms A hormone receptor-positive malignant neoplasm of the breast represents the most frequently diagnosed subtype of breast carcinoma. This specific classification indicates that the malignant cells depend upon naturally circulating reproductive hormones to sustain their cellular growth and division. Understanding the receptor status of a breast tumor is … Read more

HER2-Negative Breast Cancer: Cellular Pathology, Diagnosis, and Treatment

HER2-Negative Breast Cancer: Cellular Pathology, Diagnosis, and Treatment

1. Introduction to HER2-Negative Breast Neoplasms Breast cancer is a heterogeneous group of malignancies, meaning the disease exhibits diverse biological behaviors depending upon the specific genetic mutations present within the tumor cells. In modern oncology, defining the specific molecular subtype of the tumor is the absolute cornerstone of patient care. A HER2-negative breast cancer is … Read more

Is experiencing sharp pains in the breasts a sign of breast cancer?

Is experiencing sharp pains in the breasts a sign of breast cancer?

1. Introduction Experiencing sharp pains in the breasts is rarely a sign of breast cancer. While it is entirely understandable that any unusual sensation in the breast triggers immediate anxiety regarding malignancy, breast cancer typically presents in its early stages as a painless, hard lump. Sharp, shooting, or heavy aching pains in the breast tissue—clinically … Read more